NNC114-0005

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC114-0005, covering 2017-02-08 to 2017-02-08. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis [Phase 1]